Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al...
Transcript of Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al...
![Page 1: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/1.jpg)
www.gimsi.it
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncopeUnital
mondoreale
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncopeUnital
mondorealeMartinaRafanelli
SyncopeUnit,Geriatria eUTIG,Università degli Studi diFirenze,AOUCareggi Firenze
MartinaRafanelliSyncopeUnit,Geriatria eUTIG,
Università degli Studi diFirenze,AOUCareggi Firenze
![Page 2: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/2.jpg)
SINCOPE2 0 1 7
www.gimsi.itKennyR.A.etal.2015
Syncope is a commonmedical problem.
There is wide variation in practice of syncope evaluation, andwide variation in adoption of recommendations frompublished guidelines.
Syncope is a commonmedical problem.
There is wide variation in practice of syncope evaluation, andwide variation in adoption of recommendations frompublished guidelines.
• Higher health costs• unnecessary hospitalizations and diagnostic
procedures• prolongation of hospital stays• lower diagnostic rates• higher rates of symptom recurrences
• Higher health costs• unnecessary hospitalizations and diagnostic
procedures• prolongation of hospital stays• lower diagnostic rates• higher rates of symptom recurrences
![Page 3: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/3.jpg)
SINCOPE2 0 1 7
www.gimsi.itKennyR.A.etal.2015
![Page 4: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/4.jpg)
SINCOPE2 0 1 7
www.gimsi.itKennyR.A.etal.2015
![Page 5: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/5.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 6: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/6.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Referral from familypractitioners, ED, in-hospital and out-hospital services, orself-referral from thepatient
![Page 7: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/7.jpg)
SINCOPE2 0 1 7
www.gimsi.itKennyR.A.etal.2015
![Page 8: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/8.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Casagranda Ietal2016
Define the diagnostic pathway and themanagement of patients referred to the EDfor TLoC of suspected syncopal cause,which is still unexplained after the initialevaluation
![Page 9: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/9.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Casagranda I.etal2016
![Page 10: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/10.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoG.etal2015
![Page 11: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/11.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Casagranda Ietal2016
![Page 12: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/12.jpg)
SINCOPE2 0 1 7
www.gimsi.it
• Età>65anni+1• Noprodromi +1• ECGpatologico+1• Cardiopatia+1
≥2punti=altorischio
OESILrisk score:
• Età>65anni+1• Noprodromi +1• ECGpatologico+1• Cardiopatia+1
≥2punti=altorischio
Colivicchi F.etal.2003
• ECGpatologico+1• Scompensocardiaco+1• Ematocrito<30%+1• Dispnea+1• PAS<90mmHg +1
≥1=altorischio
SFSR:
• ECGpatologico+1• Scompensocardiaco+1• Ematocrito<30%+1• Dispnea+1• PAS<90mmHg +1
≥1=altorischio
Quinn J.V.etal.2004
• ECGpatologico/cardiopatia+3• Cardiopalmoprimadellasincope
+4• Sincopedasforzo+3• Sincopesupina +2• Prodromineurovegetativi -1• Assenzadisituazioni scatenanti-1
≥3punti=altorischio
EGSYSrisk score:
• ECGpatologico/cardiopatia+3• Cardiopalmoprimadellasincope
+4• Sincopedasforzo+3• Sincopesupina +2• Prodromineurovegetativi -1• Assenzadisituazioni scatenanti-1
≥3punti=altorischio
DelRossoA.etal.2008
ScoredirischioScoredirischio
![Page 13: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/13.jpg)
SINCOPE2 0 1 7
www.gimsi.itCostantinoGetal2014
![Page 14: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/14.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoGetal2015
![Page 15: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/15.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoGetal2015
![Page 16: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/16.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoGetal2015
![Page 17: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/17.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoGetal2015
![Page 18: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/18.jpg)
SINCOPE2 0 1 7
www.gimsi.it
CostantinoGetal2015
![Page 19: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/19.jpg)
www.gimsi.it
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncope Unital
mondoreale
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncope Unital
mondoreale
![Page 20: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/20.jpg)
SINCOPE2 0 1 7
www.gimsi.it
351Pz.consecutivi,valutatipersincopeinED
![Page 21: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/21.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Grossman A.M.etal.2016
![Page 22: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/22.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Grossman A.M.etal.2016
![Page 23: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/23.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Settembre2003-Settembre2006
![Page 24: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/24.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 25: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/25.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Sun B.J.Etal.2014
![Page 26: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/26.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 27: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/27.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 28: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/28.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 29: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/29.jpg)
SINCOPE2 0 1 7
www.gimsi.it
• Blanc J.J.Etal.Eur Heart J2002Ricoveripersincope63%
• Elesber A.A.etalAmHeartJ2005Ricoveri persincope 57.5%
• BartolettiA.etal.Eur Heart J2006Ricoveripersincope 50.1%
• Disertori M.etal.Europace 2003Ricoveri persincope 43%
• Brignole MEur HeartJ2006Ricoveri persincope 39%
• Blanc J.J.Etal.Eur Heart J2002Ricoveripersincope63%
• Elesber A.A.etalAmHeartJ2005Ricoveri persincope 57.5%
• BartolettiA.etal.Eur Heart J2006Ricoveripersincope 50.1%
• Disertori M.etal.Europace 2003Ricoveri persincope 43%
• Brignole MEur HeartJ2006Ricoveri persincope 39%
![Page 30: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/30.jpg)
SINCOPE2 0 1 7
www.gimsi.it
compared the short-term prognosis ofpatients at intermediate risk
versus those athigh risk identified factorsassociated with serious events analyzedthe currentmanagement of intermediate-riskpatients
In a cohort of patients with undetermined syncope, weprospectively compared the short-term prognosis ofpatients at intermediate risk (i.e., with stable heartdiseases or comorbidities, of any age) versus those athigh risk for cardiogenic syncope and identified factorsassociated with serious events. Secondarily, we analyzedthe currentmanagement of intermediate-riskpatients.
![Page 31: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/31.jpg)
SINCOPE2 0 1 7
www.gimsi.it
347patients,250at intermediateand97athighrisk
![Page 32: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/32.jpg)
SINCOPE2 0 1 7
www.gimsi.it
2vs27
![Page 33: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/33.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 34: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/34.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Intermediate-risk patientscould be safely discharged.In prognostic stratification,priority is to seek riskfactors for cardiogenicsyncope.
Intermediate-risk patientscould be safely discharged.In prognostic stratification,priority is to seek riskfactors for cardiogenicsyncope.
![Page 35: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/35.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Consecutive patients referred to the EDof Careggi Hospital for T-LOC in whichsyncope was suspected as the maindiagnosis, from 1 January to 30 June2010
Consecutive patients referred to the EDof Careggi Hospital for T-LOC in whichsyncope was suspected as the maindiagnosis, from 1 January to 30 June2010
![Page 36: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/36.jpg)
SINCOPE2 0 1 7
www.gimsi.it
Consecutive patients referred to the EDof Careggi Hospital for T-LOC in whichsyncope was suspected as the maindiagnosis, from 1 January to 30 June2010
Consecutive patients referred to the EDof Careggi Hospital for T-LOC in whichsyncope was suspected as the maindiagnosis, from 1 January to 30 June2010
![Page 37: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/37.jpg)
SINCOPE2 0 1 7
www.gimsi.it
ED295 patients
Admitted85 pz(29%)
Short stay60 pt(20%)
Syncope UnitFast Track
58 pt(21%)
Discharded92 pt(31%)
29%vs39%EGSYS229%vs39%EGSYS2
![Page 38: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/38.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 39: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/39.jpg)
SINCOPE2 0 1 7
www.gimsi.it
1-month-mortality rate was 0.03% (1/295)12-months-mortality rate was 5.4% (16/295)No events betweenED and SU evaluation
1-month-mortality rate was 0.03% (1/295)12-months-mortality rate was 5.4% (16/295)No events betweenED and SU evaluation
![Page 40: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/40.jpg)
SINCOPE2 0 1 7
www.gimsi.it
![Page 41: Il percorso del paziente dopo il DEA. Dal documento EHRA ... · SINCOPE 2 0 1 7 CasagrandaI et al 2016 Define the diagnostic pathway and the managementofpatientsreferred totheED for](https://reader034.fdocumento.com/reader034/viewer/2022042306/5ed2a880b9f87260d87dbe25/html5/thumbnails/41.jpg)
www.gimsi.it
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncope Unital
mondoreale
IlpercorsodelpazientedopoilDEA.DaldocumentoEHRAsullaSyncope Unital
mondoreale
Grazieperl’attenzioneGrazieperl’attenzione